AST SpaceMobile shares tumble after a major setback for the satellite maker, and Fermi sinks following the departure of its ...
This stunning aerial view of Madura Island in East Java reveals a vibrant coastal town where rows of red-roofed houses line the shoreline beside calm blue waters. Fishing boats gather along the coast, ...
Nineteen people have been charged in an Indonesian court for their alleged involvement in a trafficking ring that sent babies across the country and overseas, including to Singapore. The 19 suspects — ...
Indonesian prosecutors charged 19 people on Tuesday for their alleged roles in buying babies from new parents and selling them at a profit to clients at home and abroad in what the authorities ...
PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...
Prosecutors charged 19 people accused of sending infants to cities across the country and overseas, including to Singapore, in what the authorities described as one of Indonesia's largest trafficking ...
Ravensdale Lodge’s varied schedule of indoor competitions continued last week before the move outdoors early next month. With ...
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. By Rebecca Robbins Eli Lilly reached a deal on Tuesday to buy Centessa ...
Eli Lilly will pay up to $7.8 billion to acquire Centessa Pharmaceuticals. Centessa is developing orexin agonists to treat narcolepsy and excessive drowsiness. The deal is the latest from Lilly, which ...
Eli Lilly opposes the White House's push to codify 'most favored nation' drug pricing, Lilly CEO Dave Ricks said in an interview with CNBC. Lilly is one of more than a dozen pharmaceutical companies ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s obesity pill ...
While Lilly’s position in the obesity market and wider GLP-1 space has remained largely unshakeable in recent months, a crack in the company’s armor may be forming, according to at least one analyst.